Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Liabilities and Shareholders Equity (2016 - 2025)

HealthLynked (HLYK) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 36.02% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.9 million, a 46.63% decrease, with the full-year FY2024 number at $2.2 million, down 48.06% from a year prior.
  • Liabilities and Shareholders Equity was $1.8 million for Q3 2025 at HealthLynked, down from $1.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $13.0 million in Q3 2021 to a low of $1.8 million in Q3 2025.
  • A 5-year average of $6.0 million and a median of $5.5 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 376.54% in 2021, then tumbled 57.17% in 2022.
  • HealthLynked's Liabilities and Shareholders Equity stood at $10.7 million in 2021, then crashed by 57.17% to $4.6 million in 2022, then decreased by 6.56% to $4.3 million in 2023, then plummeted by 48.06% to $2.2 million in 2024, then decreased by 20.62% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Liabilities and Shareholders Equity are $1.8 million (Q3 2025), $1.8 million (Q2 2025), and $2.1 million (Q1 2025).